Evaluation of Absolute Oral Bioavailability and Bioequivalence of Ribociclib, a Cyclin‐Dependent Kinase 4/6 Inhibitor, in Healthy Subjects
2012 ◽
Vol 40
(10)
◽
pp. 2026-2030
◽
Keyword(s):
2006 ◽
Vol 46
(3)
◽
pp. 282-290
◽
2014 ◽
Vol 3
(6)
◽
pp. 487-492
◽
Keyword(s):
2019 ◽
Vol 8
(7)
◽
pp. 895-902
◽
2006 ◽
Vol 44
◽
pp. S231-S232
◽
2019 ◽
Vol 67
(12)
◽
pp. 3448-3458
◽
1983 ◽
Vol 24
(6)
◽
pp. 915-920
◽